- Home
- KDK vs BBNX Comparison
KDK vs BBNX Comparison
Compare KDK & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$9.48
HOLD
Current Price
$14.94
Company Overview
Basic Information| Metric | KDK | BBNX |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | KDK | BBNX |
|---|---|---|
| Price | $9.48 | $14.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | $15.63 | ★ $29.75 |
| AVG Volume (30 Days) | 667.2K | ★ 1.4M |
| Earning Date | 02-15-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $16,450,000.00 | ★ $88,570,000.00 |
| Revenue This Year | N/A | $53.58 |
| Revenue Next Year | $253.02 | $35.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.01 |
| 52 Week Low | $5.43 | $8.89 |
| 52 Week High | $11.62 | $32.71 |
Technical Indicators
Market Signals| Indicator | KDK | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 51.36 | 23.93 |
| Support Level | $8.88 | $16.02 |
| Resistance Level | $9.79 | $19.03 |
| Average True Range (ATR) | 0.73 | 1.69 |
| MACD | -0.16 | -0.71 |
| Stochastic Oscillator | 46.29 | 2.37 |
Price Performance
Historical Comparison KDK
BBNX
About KDK Kodiak AI Inc.
Kodiak AI Inc is engaged in the commercial trucking industry and the public sector, based on AI-powered autonomous vehicle technology.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.